This edition features articles on the incidence of major infections in PCI or CABG in the randomized SYNTAX trial; the PEPCAD NSTEMI trial randomising NSTEMI patients to drug-coated balloon or stents; a study of LAAO vs non-vitamin K antagonist oral anticoagulants; a look at the question of whether and when a patient is too old for TAVI; and the results of the TRICAVAL trial for severe tricuspid regurgitation comparing the implantation of a balloon-expandable transcatheter valve into the inferior vena cava (CAVI) vs medical therapy.
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)